Theravance Biopharma, Inc.
NASDAQ:TBPHBiotechnology
Healthcare
$17.03 -0.42%
-$0.07 today
- Market cap
- $882.64M
- Beta
- 0.18
- P/E (TTM)
- 7.4
- EPS (TTM)
- $2.23
52W Low $10.44High $21.03
Volume 10.02M
Average 0.43M
Private 5-step workspace
Build a TBPH investment thesis
Turn Theravance Biopharma, Inc. research into a structured decision across business quality, moat, management, intrinsic value, and synthesis.
Log in to save your stock analysis
Your answers are private and saved per stock, so you can come back to the thesis later.
Continue the stock analysis
Jump to another research area for this company.